Cronos Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Cronos Stock Summary

Cronos competes with OrganiGram Holdings, Aurora Cannabis, SNDL, Canopy Growth, and Tilray. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. Cronos operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 626 people.

Cronos Key Financial Ratios

Cronos Key Balance Sheet Accounts

Cronos Key Income Statement Accounts

Cronos Key Cash Accounts

Cronos Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cronos's current stock value. Our valuation model uses many indicators to compare Cronos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cronos competition to find correlations between indicators driving Cronos's intrinsic value. More Info.Cronos Group is number one stock in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, Cronos' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cronos' earnings, one of the primary drivers of an investment's value.

Cronos' Earnings Breakdown by Geography

Cronos Group Systematic Risk

Today, most investors in Cronos Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cronos' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cronos growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Cronos help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cronos Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cronos Group based on widely used predictive technical indicators. In general, we focus on analyzing Cronos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cronos's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.